| Published Application/Species/Sample/Dilution | Reference |
|---|
- western blot; mouse; 1:200; loading ...; fig 3l
| Zhang J, Sheng J, Dong L, Xu Y, Yu L, Liu Y, et al. Cardiomyocyte-specific loss of RMP causes myocardial dysfunction and heart failure. Cardiovasc Res. 2018;: pubmed publisher |
- immunohistochemistry - frozen section; human; 1:100; loading ...; fig 5f
| Protze S, Liu J, Nussinovitch U, Ohana L, Backx P, Gepstein L, et al. Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker. Nat Biotechnol. 2017;35:56-68 pubmed publisher |
- western blot; human; 1:200; loading ...; fig 1a
- western blot; mouse; 1:200; loading ...; fig 1c
| Xu Z, Mei F, Liu H, Sun C, Zheng Z. C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction. J Am Heart Assoc. 2016;5: pubmed publisher |
- western blot; mouse; 1:200; fig 1
| Yu C, Tang L, Liang C, Chen X, Song S, Ding X, et al. Angiotensin-Converting Enzyme 3 (ACE3) Protects Against Pressure Overload-Induced Cardiac Hypertrophy. J Am Heart Assoc. 2016;5: pubmed publisher |
- immunohistochemistry - paraffin section; human; fig 6a
| Lindskog C, Linné J, Fagerberg L, Hallström B, Sundberg C, Lindholm M, et al. The human cardiac and skeletal muscle proteomes defined by transcriptomics and antibody-based profiling. BMC Genomics. 2015;16:475 pubmed publisher |
- western blot; mouse; 1:200
| Zhang Y, Zhang X, Gao L, Liu Y, Jiang D, Chen K, et al. Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction. Biochim Biophys Acta. 2014;1842:232-44 pubmed publisher |
| Ross J, Tasfaout H, Levy Y, Morgan J, Cowling B, Laporte J, et al. rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy. Acta Neuropathol Commun. 2020;8:167 pubmed publisher |
| Xiang M, Luo H, Wu J, Ren L, Ding X, Wu C, et al. ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK - AKT Signaling. J Am Heart Assoc. 2018;7:e008604 pubmed publisher |
| Ren L, Wu C, Yang K, Chen S, Ye P, Wu J, et al. A Disintegrin and Metalloprotease-22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway. J Am Heart Assoc. 2018;7: pubmed publisher |
| Hoa N, Ge L, Korach K, Levin E. Estrogen receptor beta maintains expression of KLF15 to prevent cardiac myocyte hypertrophy in female rodents. Mol Cell Endocrinol. 2018;470:240-250 pubmed publisher |
| Tang K, Zhao Y, Li H, Zhu M, Li W, Liu W, et al. Translocase of Inner Membrane 50 Functions as a Novel Protective Regulator of Pathological Cardiac Hypertrophy. J Am Heart Assoc. 2017;6: pubmed publisher |
| Chen L, Huang J, Ji Y, Zhang X, Wang P, Deng K, et al. Tripartite motif 32 prevents pathological cardiac hypertrophy. Clin Sci (Lond). 2016;130:813-28 pubmed publisher |
| Lu J, Bian Z, Zhang R, Zhang Y, Liu C, Yan L, et al. Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy. Basic Res Cardiol. 2013;108:326 pubmed publisher |
| Czerwinska A, Streminska W, Ciemerych M, Grabowska I. Mouse gastrocnemius muscle regeneration after mechanical or cardiotoxin injury. Folia Histochem Cytobiol. 2012;50:144-53 pubmed publisher |
| Bian Z, Wei X, Deng S, Tang Q, Feng J, Zhang Y, et al. Disruption of mindin exacerbates cardiac hypertrophy and fibrosis. J Mol Med (Berl). 2012;90:895-910 pubmed publisher |
